← 產業報告目錄
Placental Stem Cell Therapy for Neurological Disorders Market Size, Share & Trends Analysis Report By Type (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), By End-User), By Region, And By Segment Forecasts, 2023-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-12頁數 180報告編號 INSIGHTACE-70e85f87dc
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 384.09 Mn as of 2022, the global Placental Stem Cell Therapy for Neurological Disorders Market is forecasted to climb to USD 2,049.44 Mn by 2031, reflecting a compound annual growth rate of 20.6% over the 2023–2031 period.
At its core, Placental Stem Cell Therapy for Neurological Disorders pertains to using stem cells derived from the placenta to treat various conditions affecting the nervous system. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
The market's upward path is supported by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Placental Stem Cell Therapy for Neurological Disorders Market Snapshot
Chapter 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
5.2.1. Allogeneic Placental Stem Cell Therapy
5.2.2. Autologous Placental Stem Cell Therapy
Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis
6.1. By End-User & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End-User:
6.2.1. Hospitals & Specialty Clinics
6.2.2. Clinics Research Organizations
6.2.3. Research Institutes & Academics
Chapter 7. Placental Stem Cell Therapy for Neurological Disorders Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
7.1.2. North America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) estimates and forecasts By End-User, 2019-2031
7.1.3. North America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, 2019-2031
7.2.2. Europe Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, 2019-2031
7.2.3. Europe Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, 2019-2031
7.3.2. Asia Pacific Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, 2019-2031
7.3.3. Asia Pacific Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
7.4.2. Latin America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, (US$ Million) 2019-2031
7.4.3. Latin America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
7.5.2. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, (US$ Million) 2019-2031
7.5.3. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Mesoblast Ltd.,
8.2.2. Pluristem Therapeutics,
8.2.3. ReNeuron Group,
8.2.4. AthersysInc.,
8.2.5. Cordlife India,
8.2.6. LifeCell International Pvt. Ltd,
8.2.7. Cryo-Cell International Inc.,
8.2.8. CBR Systems,
8.2.9. Cellularity Inc., Cynata
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們